Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 11 2022
Historique:
pubmed: 15 6 2022
medline: 2 11 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Parent hesitancy contributes to reduced HPV vaccination rates. The HPVcancerfree app (HPVCF) was designed to assist parents in making evidence-based decisions regarding HPV vaccination. This study examined if parents of vaccine-eligible youth (11-12 yrs.) who use HPVCF in addition to usual care demonstrate significantly more positive intentions and attitudes toward HPV vaccination and greater HPV vaccination rates compared to those not using HPVCF. Clinics (n = 51) within a large urban pediatric network were randomly assigned to treatment (HPVCF + usual care) or comparison (usual care only) conditions in a RCT conducted between September 2017 and February 2019. Parents completed baseline and 5-month follow-up surveys. Participant-level analysis determined 1) change in HPV vaccination initiation behavior and related psychosocial determinants and 2) predictors of HPV vaccine initiation. Parents (n = 375) who completed baseline and 5-month follow-up surveys were female (95.2%), 40.8 (±5.8) yrs. married (83.7%), employed (68.3%), college educated (61.9%), and privately insured (76.5%). Between-group analysis of HPVCF efficacy demonstrated that parents assigned to receive HPVCF significantly increased knowledge about HPV and HPV vaccination (

Identifiants

pubmed: 35699953
doi: 10.1080/21645515.2022.2087430
pmc: PMC9621032
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2087430

Subventions

Organisme : NCI NIH HHS
ID : T32 CA057712
Pays : United States

Références

Prev Med Rep. 2020 Nov 05;20:101240
pubmed: 33294312
JMIR Form Res. 2021 Nov 19;5(11):e28846
pubmed: 34806991
Arch Pediatr Adolesc Med. 2007 Mar;161(3):252-9
pubmed: 17339506
JMIR Mhealth Uhealth. 2020 May 18;8(5):e17371
pubmed: 32421684
Trials. 2016 Dec 15;17(1):599
pubmed: 27978848
J Appl Res Child. 2019;10(2):
pubmed: 32724705
Vaccine. 2011 Nov 3;29(47):8634-41
pubmed: 21924315
Lancet. 2019 Aug 10;394(10197):497-509
pubmed: 31255301
Ann Fam Med. 2012 May-Jun;10(3):235-40
pubmed: 22585888
Vaccine. 2019 Oct 23;37(45):6793-6802
pubmed: 31562000
JMIR Pediatr Parent. 2022 Feb 21;5(1):e30340
pubmed: 35188469
Hum Vaccin Immunother. 2021 Jul 3;17(7):1961-1967
pubmed: 33439768
Hum Vaccin Immunother. 2021 Apr 3;17(4):1014-1024
pubmed: 33121331
Am Psychol. 1989 Sep;44(9):1175-84
pubmed: 2782727
JMIR Mhealth Uhealth. 2015 Nov 04;3(4):e101
pubmed: 26537656
Prev Med. 2016 Oct;91:43-49
pubmed: 27471023
BMC Infect Dis. 2013 Mar 18;13:140
pubmed: 23506489
Hum Vaccin Immunother. 2018 Jul 3;14(7):1626-1635
pubmed: 29359986
MMWR Morb Mortal Wkly Rep. 2020 Aug 21;69(33):1109-1116
pubmed: 32817598
J Infect Dis. 2007 Oct 15;196(8):1153-62
pubmed: 17955433
Pediatrics. 2019 Jan;143(1):
pubmed: 30530637
Med Decis Making. 2008 Nov-Dec;28(6):834-44
pubmed: 19015289
N Engl J Med. 2020 Oct 1;383(14):1340-1348
pubmed: 32997908
J Med Internet Res. 2021 Aug 5;23(8):e26478
pubmed: 34383667
J Natl Cancer Inst. 2013 Apr 3;105(7):469-74
pubmed: 23486550
J Appl Res Child. 2019;10(2):
pubmed: 34231977
J Med Internet Res. 2020 Aug 3;22(8):e19018
pubmed: 32744508
Ethn Dis. 2020 Sep 24;30(4):661-670
pubmed: 32989366
Prev Med. 2020 Feb;131:105968
pubmed: 31881235
Hum Vaccin Immunother. 2016 Jun 2;12(6):1566-88
pubmed: 26838959
J Sch Health. 2019 Nov;89(11):916-925
pubmed: 31506951
J Pediatr. 2021 Jul;234:149-157.e3
pubmed: 33689710
Sex Transm Dis. 2011 Aug;38(8):769-76
pubmed: 21336230
JAMA. 2007 Aug 15;298(7):743-53
pubmed: 17699008
J Adolesc Health. 2018 Nov;63(5):652-656
pubmed: 30348283
Stud Health Technol Inform. 2022 Jun 6;290:819-823
pubmed: 35673132
Sex Transm Dis. 2010 Apr;37(4):234-9
pubmed: 19940807
Hum Vaccin Immunother. 2019;15(7-8):1465-1475
pubmed: 30779682
Soc Sci Med. 2009 Aug;69(3):475-80
pubmed: 19540642
Vaccine. 2021 Apr 22;39(17):2416-2423
pubmed: 33775438

Auteurs

Ross Shegog (R)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Lara S Savas (LS)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

C Mary Healy (CM)

Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

Erica L Frost (EL)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Sharon P Coan (SP)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Efrat K Gabay (EK)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Sharice M Preston (SM)

Department of Behavioral Sciences, UTHealth School of Public Health, Dallas, TX, USA.

Stanley W Spinner (SW)

Department of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA.

Mathew Wilbur (M)

Department of Pediatrics, Texas Children's Pediatrics, Houston, TX, USA.

Elisabeth Becker (E)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Travis Teague (T)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Sally W Vernon (SW)

Department of Behavioral Science, UTHealth School of Public Health, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH